BIOAVAILABILITY OF PIPEMIDIC ACID (PIPRAM) - 800-MG ONCE DAILY VERSUS 400-MG TWICE DAILY IN HUMAN VOLUNTEERS

被引：0
|
作者：
GUELEN, PJM
BOEREMA, JBJ
VREE, TB
机构：
来源：
TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH | 1987年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：71 / 75
页数：5
相关论文
共 50 条
  • [1] COMPARISON OF CIMETIDINE 800 MG ONCE DAILY AND 400 MG TWICE DAILY IN ACUTE DUODENAL ULCERATION
    CAPURSO, L
    DALMONTE, PR
    MAZZEO, F
    MENARDO, G
    MORETTINI, A
    SAGGIORO, A
    TAFNER, G
    [J]. BRITISH MEDICAL JOURNAL, 1984, 289 (6456): : 1418 - 1420
  • [2] Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation
    Kakuda, Thomas N.
    Leopold, Lorant
    Timmers, Maarten
    Van De Casteele, Tom
    Hillewaert, Vera
    Tomaka, Frank L.
    Hoetelmans, Richard M. W.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (09) : 805 - 816
  • [3] Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections
    Drehobl, M
    Koenig, L
    Barker, M
    StClair, P
    Maladorno, D
    [J]. CHEMOTHERAPY, 1997, 43 (05) : 378 - 384
  • [4] COMPARISON OF CIMETIDINE 400 MG TWICE DAILY AND CIMETIDINE 800 MG ONCE DAILY AT DIFFERENT TIMES ON DUODENAL-ULCER HEALING
    MINOLI, G
    TERRUZZI, V
    FERRARA, A
    CASIRAGHI, A
    PRADA, A
    PORRO, A
    DELLAMONICA, A
    TROTTI, R
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 40 (05): : 893 - 897
  • [5] Safety of switching raltegravir 400mg twice daily to raltegravir 800mg once daily in virologically suppressed patients
    Moore, A.
    Sonecha, S.
    Boffito, M.
    Pozniak, A.
    Asboe, D.
    Barber, T.
    [J]. HIV MEDICINE, 2017, 18 : 3 - 3
  • [6] PHARMACOKINETICS OF FLEROXACIN AFTER SINGLE AND MULTIPLE 400-MG AND 800-MG DOSAGE REGIMENS
    PANNETON, AC
    BERGERON, MG
    LEBEL, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 158 - 158
  • [7] BACTERICIDAL KINETICS AND SELECTION OF RESISTANT MUTANTS WITH ONCE-DAILY VS TWICE-DAILY DOSING WITH 400-MG OF PEFLOXACIN
    BAUERNFEIND, A
    HORL, G
    EBERLEIN, E
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S951 - S952
  • [8] CIMETIDINE, 800 MG AT NIGHT VERSUS 400 MG TWICE DAILY, IN THE TREATMENT OF DUODENAL-ULCER
    CAPURSO, L
    DALMONTE, PR
    MAZZEO, F
    MENARDO, G
    MORETTINI, A
    SAGGIORO, A
    TAFNER, G
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 : 6 - 10
  • [9] COMPARATIVE BIOAVAILABILITY AND PHARMACOKINETICS OF URIDURINE 200-MG ONCE DAILY VERSUS 100-MG 3 TIMES DAILY IN HUMAN VOLUNTEERS
    GUELEN, PJM
    BOEREMA, JBJ
    VREE, TB
    [J]. TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH, 1986, 11 (06): : 233 - 237
  • [10] PHARMACOKINETICS AND TOLERANCE OF ENOXACIN IN HEALTHY-VOLUNTEERS ADMINISTERED AT A DOSAGE OF 400-MG TWICE DAILY FOR 14 DAYS
    TSUEI, SE
    DARRAGH, AS
    BRICK, I
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 : 71 - 74
12345